Serum insulin-like growth factor-I (IGF-I) and IGF binding protein-3 levels in children with precocious puberty treated with gonadotropin-releasing hormone analog without or in combination with cyproterone acetate

Gynecological Endocrinology

Volumn 11, Issue 4, 1997, Pages 243-250

  Verrotti, A ^a   Ferrari, M ^a   Sabatino, G ^a   Morgese, G ^b   Chiarelli, F ^a,c  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c Ospedale Pediatrico   (Italy)

Author keywords

GnRH analog; IGF I; IGFBP 3; Precocious puberty

Indexed keywords

CYPROTERONE ACETATE; GONADORELIN; GONADORELIN DERIVATIVE; HORMONE ANALOG; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOMATOMEDIN BINDING PROTEIN;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; METABOLIC REGULATION; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; BLOOD LEVEL; DRUG EFFECT; GROWTH RATE;

EID: 0030792626     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.3109/09513599709152541     Document Type: Article

References (40)

1. Muñoz, M. T., Barrios, V., Pozo, J. and Argente, J. (1996). Insulin-like growth factor I, its binding proteins 1 and 3, and growth hormone-binding protein in children and adolescents with insulin-dependent diabetes mellitus: clinical implications. Pcdiatr. Res., 39, 992-8
2. Baxter, R. C. and Martin, J. L. (1989). Binding proteins for the insulin-like growth factors. Structure, regulation and function. Prog. Growth Factor Res., 1, 49-68
3. Sklar, C. A., Rothenberg, S., Blumberg, D., Oberfield, S. E., Levine, L. S. and David, R. (1991). Suppression of the pituitary-gonadal axis in children with central precocious puberty: effects on growth, growth hormone, insulin-like growth factor-I and prolactin secretion. J. Clin. Endocrinol., 73, 734-6
4. Juul, A., Scheike, T., Nielsen, C. T., Krabbe, S., Müller, J. and Skakkebæk, N. E. (1995). Serum insulin-like growth factor I (IGF-I) and IGF binding protein-3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate). J. Clin. Endocrinol. Metab., 80, 3059-67
5. DiMartino-Nardi, J., Wu, R., Varner, R., Wong, W. T. and Saenger, P. (1994). The effect of luteinizing hormone-releasing hormone analogue for central precocious puberty on growth hormone (GH) and GH-binding protein. J. Clin. Endocrinol, Metab., 78, 664-8
6. Kobayashi, Y., Murata, A., Yasuda, T., Minagawa, M., Wataki, K., Ohnishi, H. and Niimi, H. (1994). Suppression of sex steroids by a gonadotrophin-releasing hormone agonist increases serum growth hormone-binding protein activity in girls with central idiopathic precocious puberty. Clin. Endocrinol., 40, 351-5
7. Brauner, R., Malandry, F., Fontoura, M., Prevot, C., Souberbielle, J. C. and Rappaport, R. (1991). Idiopathic central precocious puberty in girls as a model of the effect of plasma insulin-like growth factor I. Horm. Res., 36, 116-20
8. Juul, A., Bang, P., Hertel, N. T., Main, K., Dalgaard, P., Jørgensen, K., Müller, J., Hall, K. and Skakkebæk, N. E. (1994). Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J. Clin. Endocrinol. Metab., 78, 744-52
9. Juul, A., Dalgaard, P., Blum, W. F., Bang, P., Hall, K., Michaelsen, K. F., Müller, J. and Skakkebæk, N. E. (1995). Serum levels of insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-I, IGFBP-2, age, sex, body mass index, and pubertal maturation. J. Clin. Endocrinol. Metab., 80, 2534-42
10. Wilson, D. M., Stene, M. A., Killen, J. D., Hammer, L. D., Litt, I. F., Hayward, C. and Taylor, C. B. (1992). Insulin-like growth factor binding protein-3 in normal pubertal girls. Acta Endocrinol., 128, 381-8
11. DiMartino-Nardi, J., Styne, D. M., Harris, D. A. and Egli, C. A. (1985). Treatment of true precocious puberty with a potent luteinizing hormone-releasing hormone factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pitiutary-gonadal axis. J. Clin. Endocrinol. Metab., 62, 142-51
12. Harris, D. A., Van Vliet, G. and Egli, C. (1985). Somatomedin-C in normal puberty and in true precocious puberty before and after treatment with a potent luteinizing hormone-releasing hormone agonist. J. Clin. Endocrinol. Metab., 61, 152-9
13. DiMartino-Nardi, J., Wu, R. and Fishman, K. (1991). The effect of LHRHa on growth hormone secretory dynamics in children with precocious puberty. J. Clin Endocrinol. Metab., 73, 902-6
14. Mansfield, M. J., Rudlin, C. R. and Crigler, J. F. (1988). Changes in growth and serum growth hormone and plasma somatomedin-C levels during suppression of gonadal sex steroid secretion in girls with central precocious puberty. J. Clin. Endocrinol. Metab., 66, 33-9
15. Sklar, C. A., Rothenberg, S. and Blumberg, D. (1991). Suppression ofthe pituitary-gonadal axis in children with central precocious puberty: effects on growth, growth hormone, insulin-like growth factor-I, and prolactin secretion. J. Clin. Endocrinol. Metab., 73, 734-8
16. Ross. J. L., Pescovitz, O. H., Barnes, K., Loriaux, D. L. and Cutler, G. B. (1987). Growth hormone secretory dynamics in children with precocious puberty. J. Pediatr., 110, 369-72
17. Rappaport, R., Prevot, C. and Brauner, R. (1987). Somatomedin-C and growth in children with precocious puberty: a study of the effect of the level of growth hormone secretion. J. Clin. Endocrinol. Metab., 65, 1112-17
18. Cara, J. F., Burstein, S., Cuttler, I., Mall, G. W. J. and Rosenfield, R. L. (1989). Growth hormone deficiency impedes the rise in plasma insulin-like growth factor I levels associated with precocious puberty. J. Pediatr., 115, 64-8
19. Pescovitz, O. H., Rosenfeld, R. G. and Hintz, R. L. (1985). Somatomedin-C in normal puberty and in true precocious puberty before and after treatment with a potent luteinizing hormone-releasing hormone agonist. J. Pediatr., 107, 20-4
20. Attie, K. M., Ramirez, N. R., Conte, F. A., Kaplan, S. L. and Grumbach, M. M. (1990). The pubertal growth spurt in eight patients with true precocious puberty and growth hormone deficiency: evidence for a direct role of sex steroids. J. Clin. Endocrinol. Metab., 71, 975-83
21. Blum,W. F.,Albertsson-Wikland,K.,Rosberg,S. and Ranke, M. B. (1993). Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein-3 reflect spontaneous growth hormone secretion. J. Clin. Endocrinol. Metab., 76, 1610-16
22. Tanner, J. M. (1962). Growth and Adolescence, 2nd edn. (Oxford: Blackwell)
23. Greulich, W. W. and Pyle, S. J. (1964). Radiographic Atlas of Skeletal Development of the Hand and the Wrist. (Stanford: Stanford University Press)
24. Reiter, E. O., Kaplan, S. L., Conte, F. A. and Grumbach, M. M. (1975). Responsivity of pituitary gonadotropes to luteinizing hormone-releasing factor in idiopathic precocious puberty, precocious thelarche, precocious adrenarche, and in patients treated with medroxyprogesterone acetate. Pediatr. Res., 29, 111-16
25. Weirman, M. E., Beardsworth, D. E., Crawford, J. D., Crigler, J. F. Jr, Mansfield, M. J. and Bode, H. H. (1986). Adrenarche and skeletal maturation during LHRH analogue suppression of gonadarche. Clin. Invest., 77, 121-6
26. Salardi, S., Orsini, L. F., Cacciari, E., Bovicelli, L. and Reggiani, A. (1985). Pelvic ultrasonography in premenarcheal girls: relation to puberty and sex hormone concentrations. Arch. Dis. Child., 60, 120-5
27. Salardi, S., Orsini, L. F., Cacciari, E., Partesotti, S., Brondelli, L. and Cicognani, A. (1988). Pelvic ultrasonography in girls with precocious puberty, congenital adrenal hyperplasia, obesity, or hirsutism. J. Pediatr., 112, 880-7
28. Gil-Ad, I., Topper, E. and Laron, Z. (1979). Oral clonidine as a growth hormone stimulation test. Lancet, 2, 278-80
29. Lanes, R., Recker, B., Fort, P. and Lifshits, F. (1985). Low-dose oral clonidine. A simple and reliable growth hormone screening test for children. Am. J. Dis. Child., 139, 87-8
30. Ghigo, E., Imperiale, E., Boffano, G. M., Bellone, J. and Arvat, E, (1990). A new test for the diagnosis of growth hormone deficiency due to primary pituitary impairment: combined administration of pyridostigmine and growth hormone-releasing hormone. J. Endocrinol. Invest., 13, 307-16
31. DiMartino-Nardi, J., Wu, R., Fishman, K. and Saenger, P. (1991). The effect of long-acting analogue of luteinizing hormone-releasing hormone on growth hormone secretory dynamics in children with precocious puberty. J. Clin. Endocrinol. Metab., 73, 902-6
32. Veldhuis J. D. and Johnson, M. L. (1986). Cluster analysis: a simple, versatile and robust algorithm for endocrine pulse detection. Am. J. Physiol., 250, 486-93
33. Blum, W. F., Ranke, M. B., Kietzmann, K., Gauggcl, E., Zeisel, H. J. and Bierich, J. R. (1990). A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: its use for diagnosis of GH deficiency. J. Clin. Endocrinol. Metab., 70, 1292-8
34. Lykkesfeldt, G., Bennett, P., Lykkesfeldt, A. E., Micic, S. Moller, S. and Svenstrup, B. (1985). Abnormal androgen and oestrogen metabolism in men with steroid sulphatase deficiency and recessive X-linked ichthyosis. Clin. Endocrinol. (Oxf.), 23, 385-93
35. Snedecor, G. W. and Cochran, W. G. (1980). Statistical Methods. (Iowa: Iowa State University Press)
36. Brauner, R., Adan, L., Malandry, F. and Zantleifer, D. (1994). Adult height in girls with idiopathic true precocious puberty. J. Clin. Endocrinol. Metab., 79, 415-20
37. Kreiter, M., Burstein, S. and Rosenfield, R. L. (1990). Preserving adult height potential in girls with idiopathic true precocious puberty. J. Pediatr., 117, 364-70
38. Knuth, U. A., Hano, R. and Nieschlag, E. (1984). Effect of flutamide or cyproterone acetate on pituitary and testicular hormones in normal men. J. Clin. Endocrinol. Metab., 59, 963-9
39. Gräf, K.-J. and Neumann, F. (1972). Influence of cyproterone acetate on sexual differentiation of male guinea pig. Z. Anat. Entwickl. Gesch., 137, 200-20
40. Argente, J., Barrios, V., Pozo, J., Muñoz, M. T., Hervás, F., Stene, M. and Hernández, M. (1993). Normative data for insulin-like growth factors (IGFs), IGF-binding proteins, and growth hormone binding protein in a healthy Spanish pediatric population: age- and sex-related changes. J. Clin. Endocrinol. Metab., 77, 1522-8